美股市场个股详情
CPRX Catalyst Pharmaceuticals
- 22.070
- -0.270-1.21%
收盘价 11/29 13:00 (美东)
- 22.200
- +0.130+0.59%
盘后 17:01 (美东)
26.32亿总市值18.70市盈率TTM
22.625最高价21.900最低价55.43万股成交量22.500今开22.340昨收1225.56万成交额0.52%换手率35.03市盈率(静)1.19亿总股本24.27052周最高3.98市净率23.38亿流通值13.00052周最低--股息TTM1.06亿流通股24.270历史最高--股息率TTM3.25%振幅0.370历史最低22.109平均价1股每手
关于Catalyst Pharmaceuticals公司
Catalyst Pharmaceuticals Inc是一家生物制药公司。该公司专注于为患有罕见、衰弱、慢性神经肌肉疾病和神经系统疾病的人开发创新疗法并将其商业化。该公司供应Firdapse，一种专利形式的磷酸阿米吡啶片，用于治疗Lambbert-eaton肌无力综合症患者。
公司介绍
公司代码CPRX
公司名称Catalyst Pharmaceuticals
上市日期2006/11/08
发行价格6.00
成立日期2002
CEOMr. Richard J. Daly
所属市场纳斯达克
员工数量167
年结日12-31
公司地址355 Alhambra Circle,Suite 801
城市Coral Gables
省份佛罗里达州
国家美国
邮编33134
电话1-305-420-3200
董事高管
- 姓名
- 职务
- 年薪
- Richard J. Daly
- Director, President and Chief Executive Officer
- 1407.69万
- Dr. Preethi Sundaram, PhD
- Chief Strategy Officer
- --
- Dr. Steven R. Miller,PhD
- Executive Vice President, Chief Operating Officer and Chief Scientific Officer
- 340.47万
- Brian Elsbernd, J.D.
- Chief Compliance Officer and Chief Legal Officer
- --
- Dr. Gary Ingenito,M.D.,PhD
- Chief Medical and Regulatory Officer
- 237.14万
- Jeffrey Del Carmen
- Executive Vice President and Chief Commercial Officer
- 250.61万
- Michael W. Kalb
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Patrick J. McEnany
- Non-Executive Chairman of the Board
- 214.65万
- Tamar Thompson
- Independent Director
- 61.04万
- Molly Harper
- Independent Director
- 36.31万
- Dr. David S. Tierney,M.D.
- Independent Director
- 37.10万
- Donald A. Denkhaus
- Independent Director
- 37.62万
- Charles B. O'Keeffe
- Lead Independent Director
- 39.72万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据